Karolinska Development AB Owners

Health Care & Life Sciences » Pharmaceuticals | Karolinska Development AB

Karolinska Development AB | Ownership

Companies that own Karolinska Development AB

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

Tredje AP-fonden

6,376,600

10.14%

-1,402,215

0.04%

08/21/2018

Östersjöstiftelsen

3,889,166

6.18%

-765,130

15.05%

11/16/2017

FAM AB

2,631,496

4.18%

1,239,461

1.73%

08/31/2017

Nordea Investment Management AB (Norway)

134,037

0.21%

-138,506

03/31/2018

SEB Investment Management AB

77,341

0.12%

12/31/2017

Danske Bank A/S (Investment Management Sweden)

26,258

0.04%

09/11/2018

Catella Fondförvaltning AB

11,000

0.02%

08/31/2018

Xact Kapitalförvaltning AB

-302,218

08/31/2018

About Karolinska Development AB

View Profile

Address	Tomtebodavägen 23A Solna AB 171 65 Sweden
Employees	-
Website	http://www.karolinskadevelopment.com
Updated	07/08/2019
Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments.